News | November 01, 2006

Morbidity Linked to Anesthesia for Infrainguinal Bypass

While general endotracheal anesthesia (GETA) is the most common type of anesthesia used in infrainguinal bypasses, a study published in the November issue of the Journal of Vascular Surgery reveals that it may not be the best strategy.

“We analyzed CPT codes to trace clinical outcomes of various anesthesia options used in patients who underwent lower extremity infrainguinal bypasses: GETA, spinal anesthesia (SA) and epidural anesthesia (EA),” said Distinguished Fellow Anton N. Sidawy, MD, chief of surgical services at the Veterans’ Affairs Medical Center and Professor of surgery at George Washington and Georgetown Universities, in Washington, D.C. “We found that GETA was associated with worse 30-day morbidity including graft failure.”

Morbidity and mortality outcomes for each anesthesia type were compared using univariate analysis as well as multivariate logistic regression to control for confounders. Compared to SA, the odds of graft failure was 43 percent higher for GETA patients, but there was no statistically significant difference in the graft failure between those who had used EA and SA.

In addition, the odds of returning to the operating room, the incidence of cardiac events (postoperative myocardial infarctions or cardiac arrest) in patients who had no history of congestive heart failure or stroke, and the incidence of pneumonia were significantly higher in patients who had their procedure under GETA. However, there was no significant difference in 30-day mortality among the three groups in the study.
For more information,

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Overlay Init